Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350: h369. https://doi.org/10.1136/bmj.h369.

Article  PubMed  PubMed Central  Google Scholar 

Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, et al. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. Int Psychogeriatr. 2015;27(1):7–17. https://doi.org/10.1017/S1041610214001963.

Article  PubMed  Google Scholar 

Ballard C, Corbett A, Howard R. Prescription of antipsychotics in people with dementia. Br J Psychiatry. 2014;205(1):4–5. https://doi.org/10.1192/bjp.bp.113.128710.

Article  PubMed  Google Scholar 

Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, et al. The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Focus (Am Psychiatr Publ). 2017;15(1):81–4. https://doi.org/10.1176/appi.focus.15107.

Article  PubMed  Google Scholar 

Fazio S, Pace D, Maslow K, Zimmerman S, Kallmyer B. Alzheimer’s association dementia care practice recommendations. Gerontologist. 2018;58(suppl_1):S1–9. https://doi.org/10.1093/geront/gnx182.

Article  PubMed  Google Scholar 

Lee D, Clark ED, Antonsdottir IM, Porsteinsson AP. A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease. Expert Opin Pharmacother. 2023;24(6):691–703. https://doi.org/10.1080/14656566.2023.2195539.

Article  PubMed  Google Scholar 

Administration USFaD. FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease. 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-agitation-symptoms-associated-dementia-due-alzheimers-disease. Accessed 27 Mar 2025.

Grossberg GT, Kohegyi E, Mergel V, Josiassen MK, Meulien D, Hobart M, et al. Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer’s dementia: two 12-week, randomized, double-blind, placebo-controlled trials. Am J Geriatr Psychiatry. 2020;28(4):383–400. https://doi.org/10.1016/j.jagp.2019.09.009.

Article  PubMed  Google Scholar 

Behl S, Slomkowski M, Chen D, Chang D, Hefting N, Lee D, et al. Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer’s disease: a 12-week, active-treatment, extension trial. J Alzheimers Dis. 2024;102(2):520–9. https://doi.org/10.3233/JAD-240491.

Article  PubMed  Google Scholar 

Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353(22):2335–41. https://doi.org/10.1056/NEJMoa052827.

Article  PubMed  CAS  Google Scholar 

Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14(3):191–210. https://doi.org/10.1097/01.JGP.0000200589.01396.6d.

Article  PubMed  Google Scholar 

Mok PLH, Carr MJ, Guthrie B, Morales DR, Sheikh A, Elliott RA, et al. Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. BMJ. 2024;385: e076268. https://doi.org/10.1136/bmj-2023-076268.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Herrmann N, Lanctot KL. Do atypical antipsychotics cause stroke? CNS Drugs. 2005;19(2):91–103. https://doi.org/10.2165/00023210-200519020-00001.

Article  PubMed  Google Scholar 

Marinheiro G, Dantas JM, Mutarelli A, Menegaz de Almeida A, Monteiro GA, Zerlotto DS, et al. Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer’s disease: a meta-analysis of randomized controlled trials. Neurol Sci. 2024;45(10):4679–86. https://doi.org/10.1007/s10072-024-07576-8.

Article  PubMed  Google Scholar 

Nakamura Y, Adachi J, Hirota N, Iba K, Shimizu K, Nakai M, et al. Brexpiprazole treatment for agitation in Alzheimer’s dementia: a randomized study. Alzheimers Dement. 2024;20(11):8002–11. https://doi.org/10.1002/alz.14282.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Aga VM. Brexpiprazole for the treatment of agitation in Alzheimer’s disease dementia: clinical uncertainties and the path forward. Am J Geriatr Psychiatry. 2025;33(3):322–9. https://doi.org/10.1016/j.jagp.2024.11.003.

Article  PubMed  Google Scholar 

Higgins JPTTJ, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. 1st ed. New York: Wiley; 2019. https://doi.org/10.1002/9781119536604.

Book  Google Scholar 

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372: n160. https://doi.org/10.1136/bmj.n160.

Article  PubMed  PubMed Central  Google Scholar 

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology. 1984;34(7):939–44. https://doi.org/10.1212/wnl.34.7.939.

Article  PubMed  CAS  Google Scholar 

Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898. https://doi.org/10.1136/bmj.l4898.

Article  PubMed  Google Scholar 

Koss E, Weiner M, Ernesto C, Cohen-Mansfield J, Ferris SH, Grundman M, et al. Assessing patterns of agitation in Alzheimer’s disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S45–50. https://doi.org/10.1097/00002093-199700112-00007.

Article  PubMed  Google Scholar 

Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37.

PubMed  Google Scholar 

Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer’s disease: the neuropsychiatric inventory caregiver distress scale. J Am Geriatr Soc. 1998;46(2):210–5. https://doi.org/10.1111/j.1532-5415.1998.tb02542.x.

Article  PubMed  CAS  Google Scholar 

Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;154:672–6. https://doi.org/10.1192/bjp.154.5.672.

Article  PubMed  CAS  Google Scholar 

Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970. https://doi.org/10.1111/j.1600-0447.1970.tb02066.x.

Article  PubMed  Google Scholar 

Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7(1):55–79. https://doi.org/10.1002/jrsm.1164.

Article  PubMed  Google Scholar 

IntHout J, Ioannidis JP, Borm GF. The hartung-knapp-sidik-jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard dersimonian-laird method. BMC Med Res Methodol. 2014;14:25. https://doi.org/10.1186/1471-2288-14-25.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. https://doi.org/10.1136/bmj.327.7414.557.

Article  PubMed  PubMed Central  Google Scholar 

Rhodes KM, Turner RM, Higgins JP. Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. J Clin Epidemiol. 2015;68(1):52–60. https://doi.org/10.1016/j.jclinepi.2014.08.012.

Article  PubMed  PubMed Central  Google Scholar 

Rover C, Friede T. Using the bayesmeta R package for Bayesian random-effects meta-regression. Comput Methods Programs Biomed. 2023;229: 107303. https://doi.org/10.1016/j.cmpb.2022.107303.

Article  PubMed  Google Scholar 

Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.